Stage 4 cancer

While most thyroid cancers are found early and carry excellent outcomes, a small but clinically important group presents with advanced disease. U.S. population data from the SEER program show that about 3% of thyroid cancers are diagnosed with distant metastases, and the 5-year relative survival in this distant stage is ~50%.

Thyroid cancer, while relatively rare, continues to be a noteworthy health concern - particularly in its most advanced form. In the United States, thyroid cancer represents approximately 2.2% of all new cancer diagnoses, with an estimated 44,020 new cases and 2,290 deaths projected for 2025. More than half of thyroid cancers are...

Stage 4 stomach cancer affects approximately 30,300 Americans annually, primarily those over 55, representing 1.5% of all cancers. While this type of oncology presents serious challenges, breakthrough treatments in advanced medical centers are transforming outcomes. Modern therapies like HIPEC, PIPAC, and dendritic cell vaccines...

Stage 4 rectal cancer is the most advanced form of colorectal cancer, characterized by the spread of malignant cells beyond the rectum to distant organs such as the liver, lungs, and lymph nodes. Early screening helps detect colorectal cancer before it reaches advanced stages. However, unfortunately, many cases of rectal cancer...

Receiving a colon cancer stage 4 diagnosis can feel overwhelming, as it means the cancer has spread to distant organs. You're not alone – this stage affects 22% of colorectal cancer patients at diagnosis. While traditional treatments offer a 13% five-year survival rate, there's genuine hope ahead. Breakthrough therapies in oncology are...

A diagnosis of stage 4 colorectal cancer means that the disease has metastasized. In other words, cancer cells have spread beyond the colon or rectum to distant organs, such as the liver, lungs, or peritoneum. Colorectal cancer stage 4 is considered the most advanced and aggressive form of the disease. According to the World Health Organization...

Pancreatic cancer is a dangerous illness with a severe clinical course and a typically negative prognosis. It is known to have one of the lowest 5-year survival rates, around 7%. The majority of patients are diagnosed at advanced stages and die within a year after the diagnosis. Stage 4 pancreatic cancer is extremely difficult to manage...

For the nearly 300,000 men diagnosed with prostate cancer yearly, a stage 4 diagnosis presents serious challenges. Yet despite the 31% five-year survival rate, many patients live considerably longer with appropriate treatment. From innovative radioligand therapies with Lutetium-177 and Actinium-225 to advanced techniques like NanoKnife...